glp-1 patches effectiveness safety weight-loss vs GLP-1 weight-loss injections Do GLP-1 Patches Really Work?

Results from two studies found no association between the use of GLP-1 receptor agonists and increased risk for suicide, suicidal thoughts or depression, findings published in JAMA Internal Medicine showed

Category-wise Analysis By Product, Ozempic Dominates the GLP-1 Receptor Agonist Market Ozempic (semaglutide) dominates with 32.1% share of the global market in 2025 , due to its strong efficacy in both glycemic control and weight management

Kanamori K, Ahmad SM, Hamid A, Lutfy K

Cadmium tolerance and phytochelatin content ofArabidopsisseedlings over-expressing the phytochelatin synthase gene AtPCS1

(Sustainable Recovery of Silver Nanoparticles from Electronic Waste: Applications and Safety Concerns)